Gastroenterology — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: GI, "the gut." Subspecialty fellowship of Internal Medicine, reached through an IM residency and then a competitive fellowship rather than matched from medical school. Organ system: the digestive tract and its accessory organs, meaning esophagus, stomach, small and large intestine, plus liver, pancreas, and biliary tree.

The 30-second version

Gastroenterology is internal medicine with a scope in its hand, the subspecialty that pairs deep physiologic reasoning (liver disease, inflammatory bowel disease, GI cancer, motility) with a full slate of hands-on procedures (colonoscopy, upper endoscopy, and advanced therapeutics). You alternate clinic days, where you manage chronic, longitudinal disease, with endoscopy days, where you diagnose and treat through the scope: remove a polyp, stop a bleed, clear a blocked bile duct. It is widely regarded as having the best pay-to-lifestyle ratio in internal medicine: top-tier income, a schedule built largely around elective procedures, and, uniquely among IM fields, a physician-controlled wealth path through ambulatory surgery center (ASC) ownership. The catch: it sits behind two doors (IM residency, then one of the most competitive fellowships in medicine), the training runway is long, and the lifestyle carries a real asterisk in middle-of-the-night call for GI bleeds.

Quick dashboard (details and sources below)
Training after med school IM residency (3) + GI fellowship (3) = 6 yrs after med school (+1 for advanced endoscopy or transplant hepatology)
Total from college start ~14 years (4 undergrad + 4 med school + 3 IM residency + 3 GI fellowship)
Entry Two-step: match Internal Medicine from med school, then match GI fellowship
Competitiveness (as an IM fellowship) Very high — ~99.5% fill, ~1.6 applicants/position, ~38.5% of GI-preferring applicants go unmatched ⟳
Typical full-time pay $530,000 (Medscape 2026) · $537,870 (Doximity 2025). Production-weighted group data runs higher, in the low $600,000s, but reaches this page through a trade relay rather than from AMGA directly ⟳
Pay ceiling (the real story) Ownership of an endoscopy center is the lever, and no publisher measures what it is worth. Every specific ceiling figure on this page came from an aggregator and has been removed ⟳
Lifestyle Largely elective, schedulable procedures — but genuine GI-bleed/ERCP call at nights and weekends
Burnout 43.5% against a 41.9% all-physician average (AMA 2025), tied with cardiology at the foot of the nine specialties it names as most burned out. A GI-specific Medscape report measuring burnout, depression, or both puts that composite at ~53% ⟳
% women 40.6% of active fellows (ACGME AY2024-25), rising from a historically low base; practicing workforce skews more male ⟳
DO / IMG accessibility Reached via IM — the most DO/IMG-friendly residency; ~29% IMG + ~15% DO of matched GI fellows ⟳

What they actually do

Gastroenterologists diagnose and treat disorders of the entire digestive system: esophagus, stomach, intestines, liver, pancreas, and biliary tree. The work is a genuine procedural + cognitive blend, which is the field's signature. On the cognitive side, GIs manage chronic and complex disease over years: inflammatory bowel disease (Crohn's and ulcerative colitis, with biologic immunotherapy), chronic liver disease and cirrhosis, GI cancers and cancer screening, reflux, motility disorders, and nutrition. On the procedural side, they perform endoscopy, threading a flexible, camera-tipped scope into the gut to see and act: biopsy suspicious tissue, remove precancerous polyps, band bleeding varices, dilate strictures, place stents, and clear stones.

The clinical rhythm is unlike the ED's shift model or a pure clinic practice. A typical week alternates clinic blocks (longitudinal disease management) with endoscopy blocks (procedure-dense, efficient, repetitive). A common structure is roughly ~2 days of clinic and ~3 days of procedures, split into morning/afternoon sessions.1 Advanced practitioners increasingly function as "minimally invasive surgeons of the gut": endoscopic techniques have replaced open surgery for many conditions (bile-duct stones, early GI cancers, GI bleeding).

Representative procedures: colonoscopy (screening and therapeutic) · esophagogastroduodenoscopy (EGD / upper endoscopy) · polypectomy and endoscopic mucosal resection · esophageal/pyloric dilation and stenting · variceal banding for GI bleeding · percutaneous endoscopic gastrostomy (PEG) tube placement · paracentesis and liver biopsy · and, in advanced/interventional practice, ERCP (clearing bile/pancreatic ducts) and endoscopic ultrasound (EUS).

A week in the life: Clinic days are longitudinal, and you see IBD patients you've followed for years, adjust biologics, counsel a newly diagnosed cirrhotic, work up dysphagia. Endoscopy days are a different tempo entirely: back-to-back scheduled scopes, a tech and often an anesthesia provider at your side, the satisfaction of an immediate, concrete result (a polyp removed, a duct cleared). Then there's the asterisk that outsiders underestimate: call. GI bleeds don't keep business hours, whether variceal hemorrhage, food impactions, or cholangitis needing urgent ERCP, so you carry after-hours and weekend coverage, with frequency driven heavily by group size.1

The training path & time to completion

GI is a subspecialty, reached through Internal Medicine rather than directly from medical school. The full chain: Medical school (MD or DO, 4 yrs) → Internal Medicine residency (3 yrs) → Gastroenterology fellowship (3 yrs, ACGME) → board-eligible with ABIM Gastroenterology.2 Then, optionally, a +1 year of subspecialization.

  • Standard GI: 6 years after medical school (3 IM + 3 GI), roughly ~14 years from the start of college (4 undergrad + 4 med + 3 + 3).2
  • The optional 4th year (+1): Transplant hepatology (1 yr, ACGME, its own ABIM certification) or advanced/interventional endoscopy (1 yr, covering ERCP, EUS, and complex therapeutics, a recognized but non-boarded subspecialization). Either makes it 7 years after med school.2
  • Boards (ABIM): ABIM Gastroenterology requires completing the 3-year ACGME GI fellowship (after IM certification). ABIM Transplant Hepatology requires prior GI certification; the standard route is a 1-year transplant-hepatology fellowship, though a combined/dual pathway allows transplant-hepatology certification within the 3-year GI fellowship (ABIM only).2

The two-step entry, and why it matters for who can reach this field. Unlike EM or surgery, you don't have to win a competitive match straight out of medical school. You first match Internal Medicine, the largest and among the most DO- and IMG-accessible residencies in the country, and only then compete for a GI fellowship spot. That structure is a double-edged sword: the front door (IM) is wide, but the second door (GI fellowship) is one of the narrowest in medicine (see below).

How competitive is it?

GI is in the elite tier of Internal Medicine fellowships. Consistently near the very top by fill rate and applicant-to-position ratio, alongside Cardiology and Hematology/Oncology. But its competitiveness has a distinctive shape: it is a "hyper-competitive but tiny" field. Entry is through the NRMP Medicine Subspecialty (Fall) Match, not the main residency match.3

For the 2025 Match cycle (appointment year 2026):

  • 759 certified positions across 254 programs, of which 755 filled, a 99.5% fill rate (only 4 unfilled).3 ⟳
  • ~1,247 active applicants preferred GI (1,241 ranked it first) for those 759 spots, an applicant-to-position ratio of ~1.6:1.3 ⟳
  • The number that matters most: ~38.5% of applicants who preferred GI did NOT match into it (overall match rate ~60.5% among GI-preferring applicants).3 ⟳
  • Among IM subspecialties with ≥150 positions, GI's 99.5% fill rate ties it for 2nd, behind Cardiovascular Disease (100%, 1,347 positions) and tied with Hematology & Oncology (99.5%, 809 positions). Across all 19 IM subspecialties in that match, 7,421 positions were offered and 88.4% filled, so GI sits well above that average.3 ⟳

Match odds differ sharply by applicant class: among applicants who ranked at least one GI program, US MD graduates matched at 80.3% (421 of 524), US DO graduates at 55.6% (114 of 205), non-US IMGs at 46.7% (162 of 347) and US IMGs at 33.9% (58 of 171), reflecting both GI's competitiveness and a strong US-MD advantage.3 ⟳

The honest read: GI is reachable through a route that is itself accessible (IM), which is exactly why it's such an attractive target for DO and IMG applicants, but the fellowship gate is unforgiving, and a strong IM record, research, and mentorship are effectively required to clear it. Getting into IM is the easy part; getting the GI spot is not.

Compensation — the robust version

GI is consistently one of the highest-paid IM subspecialties, second only to cardiology in most surveys, and its pay data spans an unusually wide range, because the single biggest differentiator is procedural volume (endoscopy) plus ownership economics: ASC equity and ancillary revenue (anesthesia, pathology). A note on sources first: surveys that capture production and ASC distributions (AMGA, MGMA percentiles) report much higher figures than salary surveys that mostly capture employed clinical pay (Medscape, recruiter data). Both are cited below so the spread is transparent.456

National number. The two national surveys agree closely. Doximity's 2025 report puts GI's average total compensation at $537,870, 13th of all specialties; Medscape's 2026 report puts it at ~$530,000, up about 3% year over year. Medscape's 2025 edition had it at ~$495,000, so the field recovered a 2024 dip.456 ⟳

AMGA's medical group survey runs materially higher, in the low $600,000s, because it is production-weighted and captures group practice rather than employed physicians. Two things keep it off the headline here: AMGA's public release names no specialty at all, and the trade relays that carry the GI figure do not agree with each other on it, giving $633,422 and $644,422 for the same edition. The direction is real and the exact number is not readable.7 ⟳ (Note: BLS does not publish a GI-specific wage series, since GI folds into "Physicians, All Other" and "General Internal Medicine Physicians," so BLS is not a reliable GI benchmark.)6

The spread, and the part this page can no longer show you. GI's distribution is genuinely wide, and no publisher gives you its shape. MGMA reports percentiles inside DataDive, which is gated. The American Society for Gastrointestinal Endoscopy runs a real Gastroenterology Compensation Benchmarking survey with more than fifty benchmarks, and it is participation-gated too; its current round is collecting 2025 data and closes in August 2026, so nothing from it is published yet. AMGA reports medians only, and its press release names no specialty at all.8 ⟳

This page previously printed a four-point wRVU percentile ladder running to a 90th percentile of $817,400, and, separately, a top-earner figure of $2,450,000+. Both came from a single content site republishing figures it attributed to MGMA without being able to link to MGMA. Searching for that $2.45 million figure independently returns exactly one host: the same site. No survey, society publication, or peer-reviewed study anywhere gives a 90th-percentile gastroenterology compensation figure. Both are gone.8 ⟳

Seniority moves the number modestly, and practice model moves it enormously. That much is agreed everywhere. What nobody publishes is by how much. The employed-versus-partner-versus-owner ladder this page used to print in dollars traced back to the same excluded sources as the percentile ladder, so it has come out and the mechanism below has stayed in. Treat the gap between the two national surveys and the AMGA group figure, roughly $530,000 against the low $600,000s, as the closest published proxy for what practice model is worth.7 ⟳

ASC and endoscopy-center ownership is the biggest lever, and GI's defining wealth path. This is what separates GI from every other IM subspecialty. A physician-owned ambulatory surgery center lets a gastroenterologist capture the facility fee on every colonoscopy and EGD rather than the professional fee alone, and the facility fee is the larger of the two by a wide margin. The gastroenterology literature says so plainly: a 2011 review in Clinical Gastroenterology and Hepatology on ASC ownership models, and a 2005 Gastrointestinal Endoscopy piece written for interviewing fellows, both conclude that total reimbursement to an endoscopist is greatest in a facility they own.9 ⟳

What nobody publishes is how much. No survey, no society report, and no peer-reviewed study puts a dollar figure on ASC distributions per physician. The specific numbers that circulate, whether "$75,000 to $200,000 a year" or "$540,000 in distributions on a 15% stake," come from trade and SEO content citing each other, and this page was one of the places they landed. They are gone. Ownership economics are real, they are the reason the field's income ceiling is high, and the size of the effect is not measured.9 ⟳

Ancillary revenue (anesthesia, pathology). Beyond facility fees, GI groups commonly add income by bringing anesthesia (monitored anesthesia care for endoscopy) and pathology (biopsy/polyp reads) in-house or into joint ventures. Both are well-documented GI income levers, though no survey publishes a per-physician dollar figure for them.9

Geography.

  • By region, from recruiting offers: Northeast ~$601,250 · Midwest ~$550,000 · Southwest ~$535,714 · West ~$514,258 · Southeast ~$417,828. These are Merritt Hawkins starting salaries relayed by a staffing agency rather than read from the recruiting-incentives review itself, so treat the ordering as more reliable than the individual numbers, and remember that starting offers sit below mid-career pay by construction.10 ⟳
  • By metro: the metro-level figures this page carried, and an NYC high-end of ~$980,900, came through the same excluded republisher and have been removed. AMGA's own release names no specialty, so nothing publicly readable supports a GI figure by metro.7 ⟳
  • Urban vs. rural: non-metro/shortage markets (ID, LA, NV, HI, UT) pay above major-metro averages due to recruiting difficulty. HRSA projects a GI workforce shortage of ~720 FTEs by 2028 and ~1,390 by 2037, concentrated in non-metro areas, sustaining rural pay premiums and larger sign-on bonuses.10 ⟳
  • Sign-on bonus: commonly offered, and larger in rural and shortage markets. AMN publishes a signing-bonus average across all physicians rather than by specialty, so the GI-specific dollar figures this page carried are gone.107 ⟳
  • Tax note: Texas and Florida, with no state income tax, yield the highest net take-home, and California's top rate of 13.3% materially compresses net income. That is arithmetic rather than a compensation finding, and it holds in any specialty.

Academic vs. private. Private practice pays more, and this is one of the most consistent patterns in medicine. The specific gap figures this page carried, an ~$49,500 spread and a starker employed-sample cut, came from the removed sources and are not replaced. Across surgery and radiology, where the gap has been measured in peer-reviewed work on MGMA and AAMC data, it runs somewhere between 16% and 32% depending on the field, which is the right order of magnitude to expect. ⟳

Locum tenens. GI locum work is well paid and widely used to cover rural and shortage markets. The hourly and daily rates this page quoted came from a staffing agency's own marketing, which is the seller publishing the price, so they are gone. ⟳

The trend that colors all of it. Comp had a modest 2024 dip (Medscape $512K→$495K) and has roughly recovered (+3% YoY into 2026), but the underlying pressure is real: Medicare payments for colonoscopy and EGD fell >22% (inflation-adjusted) from 2018–2023, squeezing professional-fee income and increasing the relative importance of ASC/facility and ancillary revenue.7 Meanwhile private-equity consolidation of GI groups continues to restructure compensation (base + equity/earnout vs. traditional partnership), with PE-owned employed pay ($475K–$575K) generally below independent-partner pay.10 The takeaway: the eye-popping GI incomes are increasingly a story about ownership, and the path to them runs through partnership, not a paycheck.

Lifestyle & the pay-to-lifestyle bargain

GI's reputation as the best pay-to-lifestyle ratio in internal medicine is broadly earned, but it comes with one honest asterisk.

The good. Much of the work is elective and schedulable: outpatient endoscopy is highly plannable, clinic runs on a calendar, and, relative to cardiology or general surgery, GI is meaningfully more controllable. Average hours run ~50/week, with a wide range: some report 40 or fewer in controlled private-practice arrangements, others 55–60+ when hospital-employed with heavy inpatient consult loads.1 The strongest lever on schedule control is, again, ownership, since owners report markedly better control than employed or academic physicians.1

The asterisk: GI-bleed call. This is not a pure "shift" specialty. GI carries genuine after-hours obligation: middle-of-the-night activations for acute GI bleeds, variceal hemorrhage, food impactions, and cholangitis (urgent ERCP). Call frequency depends heavily on group size: small groups may cover every other night/weekend; large groups may be down to one week or 1–2 weekends per month, with inpatient consult volume during call weeks running ~2–5 consults/procedures daily.1 The procedural call keeps you tethered in a way outpatient-only IM subspecialties are not.

Lifestyle rating: 4/5. High in predictability and schedulability (elective procedures, clinic calendar), lowered by the real, unavoidable procedural call that comes with the anatomy.

Wellbeing — the part to take seriously

Burnout: middle of the pack. The AMA's 2025 Organizational Biopsy puts gastroenterology at 43.5% against a 41.9% all-physician average, tied with cardiology at the foot of the nine specialties it names as most burned out.11 Medscape's 2025 GI-specific mental-health reporting measures a different thing, the composite of burnout, depression, or both, and puts it at ~53% (29% burnout, 10% depression, 14% both); its 2024 cross-specialty report placed GI around 50% against a 49% average.1211 ⟳

Satisfaction runs high, though the figure usually quoted for it has no publisher. GI is widely reported at a 94–95% "would choose it again" rate. That number is gone from this page. Medscape stopped publishing would-choose-again by specialty around 2019, and the paired tables still circulating on salary aggregators are revivals of the retired one, so a reader who goes looking finds nothing behind it.11 What is currently published is a different question: Medscape's 2025 wellbeing report asked whether doctors in a specialty can be happy and well balanced, and ~79% of gastroenterologists said yes, near the top of the field.12 ⟳ Self-reported career satisfaction runs ~4.1/5, with private practice (~4.5/5) above academic (~3.7/5).18 ⟳

The satisfaction paradox. For all of that, roughly two-thirds (~64%) say they'd accept lower pay for better work-life balance. A field can be loved and still cost more than people want to pay for it.712 The named pain points are consistent: EMR/charting and administrative burden, and the physical toll of high-volume scoping, where repetitive-strain and musculoskeletal injury from endoscopy posture is a documented occupational concern.1

Career longevity. Endoscopy is physically demanding, and the ergonomic strain of scoping is a real long-term issue. But the specialty supports long careers, and, crucially, ownership and part-time scaling let senior physicians taper procedural volume while preserving income, an off-ramp that many high-intensity fields lack.1

Who's in the field (demographics)

  • Women: GI has historically had one of the lowest proportions of women among IM subspecialties. Across 2009–2019, women averaged ~33.6% of GI fellowship positions, rising only ~3.3 points across the decade. The current figure is 40.6%: 873 of 2,152 active GI fellows across 242 programs (ACGME Data Resource Book, AY2024-25).13 ⟳ The practicing workforce skews further male than the fellow pool, with women estimated in the high teens to ~20%, so the fellow pipeline is the leading edge of a slow upward shift, and it has moved further than the decade trend alone would have predicted.13 ⟳
  • IMG: Among matched GI fellows (2025 Match / AY2026), non-US IMG ~21.5% plus US IMG ~7.7% makes ~29.2% combined, and non-US IMG share is the only applicant class that grew meaningfully over the past 5 years (from ~17.4% in 2022).3 ⟳
  • DO: ~15.1% of matched GI fellows.3 ⟳
  • US MD: ~55.8% of matched fellows.3 ⟳
  • URiM: the 2025-cycle match breakdowns stop at medical-school-origin categories, so they carry no URiM figure at all. The literature describes GI representation as low without putting a current percentage on it.3

Culture, personality & the online stereotypes

Who gravitates here: physicians who want a procedural and cognitive balance, people who like working with their hands (scoping) but also enjoy the physiology and longitudinal disease management of internal medicine. There's a pragmatic, results-oriented streak: immediate wins (stopping a bleed, removing a polyp, clearing a duct) alongside chronic-care relationships (IBD, cirrhosis). The field also draws entrepreneurial, business-minded physicians attracted to the ASC/practice-ownership economics. As always, plenty of people in the field do not fit any single mold.14

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

  • "Best pay-to-lifestyle ratio in internal medicine." Widely repeated and broadly fair as a generalization, but it glosses over GI-bleed call and the physical/administrative grind.
  • "Scope monkeys" / "poop doctors." A dismissive framing implying GI is mindless repetitive scoping. Unfair: it ignores the substantial cognitive breadth (hepatology, IBD immunology, GI oncology, nutrition, motility) and the real skill and judgment in advanced endoscopy.
  • "They just chase ASC money." A cynical read of the ownership model. Unfair edge: physician-owned ASCs are a legitimate, patient-access-improving delivery model; reducing the whole specialty to money-chasing erases the clinical substance and the physicians who prioritize academic or underserved-care work.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums, the dominant read is that GI is the "smart money" IM subspecialty, with top-tier pay and a lifestyle far better than surgery and better than cardiology. Trainees frequently frame it as the reward at the end of a hard, competitive fellowship match. Recurring themes: awe at private-practice/ASC incomes; ongoing debate over whether the 6-year runway and fellowship competitiveness are "worth it" versus hospital medicine; repeated acknowledgment that GI-bleed call is real and underappreciated by outsiders; and warnings that lifestyle varies enormously by employment model (employed hospital GI vs. owner). Applicants also discuss the distinctive anxiety of a match where a meaningful share of committed applicants don't match at all.

Voices from the field. Paraphrased from public writing, with links to the originals:

  • A gastroenterologist writing for KevinMD describes GI daily life as rewarding but unpredictable, with mixed clinic and procedure weeks, night calls for bleeds, a feeling of "never off duty," and mounting computer and administrative work, yet grounded in genuine enjoyment of patient care.15
  • A gastroenterologist in Doximity's Op-Med frames GI as an "all-you-can-eat buffet" spanning oncology, immunology, infectious disease, and minimally invasive procedures, and credits deliberate geographic and lifestyle choices during fellowship for his wellbeing.16
  • The Medscape Gastroenterologist Mental Health & Well-Being Report (2025) documents the burnout-and-optimism split, with mid-pack burnout coexisting with high optimism that balance is attainable.12

Why people choose it / why people leave

Why choose it: top-tier IM compensation ($530,000 on Medscape 2026, $537,870 on Doximity 2025, with a real ownership ceiling above it that nobody has measured) · excellent pay-to-lifestyle ratio relative to other high-earning fields · largely elective, schedulable procedural work · a genuine procedural + cognitive blend (hands-on scoping plus deep IM physiology) · a concrete, physician-controlled wealth path via ASC/practice ownership · reached through the accessible IM route.

Why leave or avoid it: real GI-bleed and ERCP call at nights and weekends, so not a pure shift specialty · physically demanding scoping with repetitive-strain/musculoskeletal risk over a career · heavy EMR/administrative burden · a long, competitive runway (6 years post-MD and a fellowship where a large share of committed applicants don't match) · lifestyle quality highly employer-dependent (employed hospital GI can mean 50+ hrs and unpredictable activations) · professional-fee reimbursement pressure and PE consolidation reshaping the economics.

Best fit if: you enjoy procedures but don't want to be a surgeon, and want to keep the cognitive/longitudinal side of medicine · you're entrepreneurial and open to practice/ASC ownership · you want top-tier income without cardiology- or surgery-level lifestyle sacrifice · you can tolerate procedural call and value schedule control enough to pursue ownership.

Not for you if: you want zero after-hours/emergency obligation (consider derm, allergy, or a pure outpatient IM subspecialty) · you dislike repetitive procedural work or physical/ergonomic strain · you want the shortest path to attending life (GI adds 3 fellowship years and a tough match) · you're squeamish about the anatomy or subject matter.

The FLI angle — Gastroenterology for first-gen, low-income & immigrant students

GI is one of the strongest FLI wealth plays in medicine, and, unusually for a field this lucrative, the entry route is comparatively accessible. That combination is the whole reason it deserves a hard look from first-gen, low-income, and immigrant students.

Where GI fits FLI realities well:

  • An accessible entry route into an elite field. You don't have to win a cutthroat match straight out of medical school. GI is reached through Internal Medicine, the largest and among the most DO- and IMG-friendly residencies in the US, and then you compete for the fellowship. In the 2026 GI match, non-US IMGs filled ~21.5% and US DOs ~15.1% of positions, meaning more than 1 in 3 spots went outside the US-MD track.3
  • Top-tier pay + strong lifestyle without an elite pedigree. A GI income of roughly $530,000, with a partnership-and-ownership path above it, alongside a better-than-surgery lifestyle, is unusually attainable for someone who enters through a non-elite IM program and performs well.
  • The ownership wealth ladder. ASC and practice equity is a rare, physician-controlled path toward generational wealth, a genuine lever for someone starting from zero family capital, and ownership also buys the best schedule control. Go in knowing the size of the prize is not published anywhere, so you will be negotiating a buy-in without a benchmark.91

Risks to name honestly:

  • The second door is narrow. Getting the GI spot is hard: ~38.5% of committed GI applicants don't match, and match rates run lower for DO (55.6%), non-US IMG (46.7%), and US IMG (33.9%) applicants than for US MD graduates (80.3%).3 Clearing that gate takes a strong IM record, research, and mentorship, which is harder to assemble without connections, and the piece FLI students most need to actively build.
  • A long runway of deferred earnings. 6 years of post-MD training (7 for advanced tracks) is real opportunity cost when you're supporting family or carrying debt.
  • Procedural call is part of the deal. Nights and weekends, hardest early-career when you have the least schedule leverage.
  • Ownership isn't guaranteed. The ownership outcomes require buying into (and often being invited into) a partnership; hospital-employed GI is still excellent pay, but without the ownership multiplier.

Bottom line: GI is one of the best pay-to-lifestyle deals in all of medicine, and it sits at the end of a route (IM → fellowship) that is far more open to DO and IMG applicants than most fields this well-compensated. The catch is the second door, a hyper-competitive fellowship, and a long runway before the payoff. If you can build the record to clear the fellowship gate, few fields offer a comparable combination of accessible entry, top-tier income, a livable lifestyle, and a physician-controlled wealth path.

Subspecialties & fellowships (the +1 tracks)

None beyond the core GI fellowship are required to practice general gastroenterology. Each of these is an optional focus or extra year.2

  • Advanced / interventional (therapeutic) endoscopy. +1 year (non-ACGME/non-boarded) in ERCP, EUS, stenting, and endoscopic tumor resection; the "minimally invasive surgeon" of GI, with the highest procedural intensity in the field. It is widely believed to carry a scarcity premium over general GI, and no survey measures one.17
  • Transplant hepatology. +1 year (ACGME, ABIM-certified) in liver disease and liver transplantation; cognitive, longitudinal, high-acuity, less scope-heavy, and often academic, which usually means below general GI rather than above it.17
  • Inflammatory bowel disease (IBD). Crohn's and ulcerative colitis focus (no additional fellowship required; optional); immunology-heavy, biologic therapy, strong longitudinal relationships, often academic. Clinic-based with lower procedural volume, so below general GI.17
  • Motility / neurogastroenterology. Disorders of gut function and motion (dysphagia, gastroparesis, functional GI disorders); specialized diagnostics, more cognitive and outpatient, intellectually distinctive with lower procedure volume, and lower-paid for the same reason.17
  • General GI + ASC ownership. Not a fellowship, and the highest-earning path of all, driven by colonoscopy volume and facility-fee capture rather than by extra training.17

Fun facts

  • Colonoscopy screening volume is the economic engine of GI. The same procedure that anchors clinical throughput also anchors ASC facility-fee revenue.
  • On a screening colonoscopy, the facility fee paid to the endoscopy center is several times the professional fee paid to the gastroenterologist reading it. That single gap is why ownership, rather than scoping volume, is the field's wealth path, and why no salary survey captures what a senior GI partner actually earns.9
  • Nearly eight in ten gastroenterologists say happiness and balance are attainable in the specialty (Medscape 2025), even as ~64% would trade some pay for better work-life balance.712
  • GI is a rare "hyper-competitive but tiny" field: the fellowship match runs above 99% fill annually, yet a large share of applicants who prefer GI don't match at all in a given year.3
  • Advanced endoscopy has increasingly replaced surgery for many conditions (bile-duct stones, early GI cancers, bleeding), making GI in effect a minimally invasive surgeon of the gut.
  • The field spans an unusually broad clinical map, from liver transplant medicine to autoimmune IBD to GI cancer screening, under one specialty umbrella.

Sources

Footnotes

  1. GI lifestyle, hours, scope-day rhythm, call/GI-bleeds, controllability, satisfaction, and career longevity. SalaryDr, Gastroenterology Work-Life Balance (https://www.salarydr.com/specialty-lifestyle/gastroenterology, 2026); ICGI, "What Hours Does a GI Doctor Work?" (https://www.icgi.org/what-hours-does-a-gi-doctor-work/, 2026); Matthew Moeller, MD, KevinMD (https://kevinmd.com/2016/04/this-is-what-life-is-like-for-a-gastroenterologist.html, 2016). SalaryDr panel size: n=100. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9

  2. GI training path, years, optional +1 tracks, and ABIM certification (Gastroenterology; Transplant Hepatology). AASLD Hepatology Training Pathways (https://www.aasld.org/hepatology-training-pathways, 2026); ABIM certification policies (abim.org, 2026). ↩ ↩2 ↩3 ↩4 ↩5

  3. NRMP Medicine Subspecialty (Fall) Match, 2025 cycle / AY2026 — positions, programs, fill rate (99.5%), applicants, applicant-to-position ratio (~1.6:1), unmatched share (~38.5%), IM-subspecialty ranking, and medical-school-origin demographics (US MD 55.8%, non-US IMG 21.5%, US DO 15.1%, US IMG 7.7%) with class-specific match rates. NRMP, "NRMP Celebrates Results for the 2025 Medicine and Pediatric Specialties Match" (https://www.nrmp.org/about/news/2025/12/nrmp-celebrates-results-for-the-2025-medicine-and-pediatric-specialties-match/, Dec 2025); AMA, "Dig into NRMP fellowship Match data for medicine, pediatrics" (https://www.ama-assn.org/medical-residents/medical-fellowships/dig-nrmp-fellowship-match-data-medicine-pediatrics); Becker's ASC, "2026 gastroenterology fellowship match: A breakdown" (https://www.beckersasc.com/gastroenterology-and-endoscopy/2026-gastroenterology-fellowship-match-a-breakdown/, 2026); imgprep (https://www.imgprep.com/gastroenterology-fellowship-img). The four class-specific match rates are computed here from NRMP's own Tables 1A through 1D, on the denominator of applicants who ranked at least one program: US MD 421 matches of 524 applicants, US DO 114 of 205, US IMG 58 of 171, non-US IMG 162 of 347. NRMP, Results and Data: Specialties Matching Service, 2026 Appointment Year, February 2026, https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf Corrected 2026-08-17: three of the four rates were off against those tables. The page had US MD seniors 79.4% (80.3%), US DO 57.9% (55.6%) and non-US IMG 47.2% (46.7%); only US IMG 33.9% was exact. The DO figure is the one that mattered, because the FLI section rests on it and it ran 2.3 points high, making the DO route look more open than NRMP's own table does. "US MD seniors" is also a main-residency-match term; a fellowship match has graduates, and NRMP's table header reads "U.S. MD Graduates." Corrected 2026-08-17: the all-IM-subspecialty comparison read "across all 18 IM subspecialties, 6,721 positions were offered and 88.8% filled." Table 1A lists nineteen subspecialties under internal medicine for the 2026 appointment year, offering 7,421 positions of which 6,559 filled, 88.4%. The 6,721 and 88.8% reproduce exactly for the seventeen remaining once hospice and palliative medicine (478 offered, 380 filled) and sleep medicine (222, 208) are removed, so the arithmetic was sound and the count was the error. The full set is now used, and the comparison it draws is unchanged. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13

  4. Doximity 2025 Physician Compensation Report (2024 data) — GI avg total comp $537,870, ranked 13th of all specialties. Via Scope Forward / GI & Endoscopy News (https://scopeforward.com/gi-ranks-just-out-of-top-10-for-md-pay-doximity-reports-gi-endoscopy-news/, 2025); official: https://www.doximity.com/reports/physician-compensation-report/2025. ↩ ↩2

  5. Medscape Gastroenterologist Compensation Report 2026 (2025 data) — ~$530,000, +3% YoY, comp "primarily driven by RVU generation and procedural (endoscopy) volume." Nuaxia summary (https://www.nuaxia.com/post/medscape-gastroenterologist-compensation-report-2026, 2026). ↩ ↩2

  6. Medscape 2025 GI report (2024 data, ~$495,000) and BLS note (no GI-specific wage series). Becker's ASC, "2025 GI compensation: 8 notes" (https://www.beckersasc.com/gastroenterology-and-endoscopy/2025-gi-compensation-8-notes/, 2025); BLS OEWS: the two rows a gastroenterologist is counted in are Physicians, All Other (SOC 29-1229) at a $262,040 mean and General Internal Medicine Physicians (SOC 29-1216) at $267,200, both May 2025 wages and neither a GI figure. US Bureau of Labor Statistics, Occupational Employment and Wages — May 2025, Table 1 (https://www.bls.gov/news.release/archives/ocwage_05152026.htm). ↩ ↩2 ↩3

  7. AMGA Medical Group Compensation and Productivity Survey, and what is and is not readable in it. AMGA's 2025 edition is its 38th, covering 2024 data from about 500 medical groups and more than 184,500 providers. AMGA's own public press release reports aggregate category movement only and names no specialty, so every GI figure attributed to it reaches this page through trade press: https://www.amga.org/about-amga/newsroom/press-releases/2025/june/new-amga-survey-notes-significant-gains-in-physician-compensation . Two Becker's ASC articles give $633,422 and $644,422 as the AMGA GI median for the same edition, and both hosts return HTTP 403 to automated tools, so neither could be read directly. The $633,422 figure is the likelier of the two, since it reappears elsewhere as the prior-year comparison. This page therefore gives the AMGA read as "the low $600,000s" rather than to the dollar. Related figures previously carried here and now removed for the same reason: new-attending ~$553,000, experienced (11+ yrs) ~$643,500, an employer-type breakdown, sign-on and incentive-bonus dollars, and an NYC high end of ~$980,900. Kept, because it is a reimbursement trend rather than a compensation figure: Medicare payment for colonoscopy and EGD fell more than 22% in inflation-adjusted terms between 2018 and 2023. Relays: Becker's ASC, "The 10 pay stats GI specialists need to know" (https://www.beckersasc.com/gastroenterology-and-endoscopy/the-10-pay-stats-gi-specialists-need-to-know/, 2025); AMN Healthcare (https://www.amnhealthcare.com/blog/physician/perm/gastroenterologist-salary-guide-2025/, 2025). ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  8. The gastroenterology spread, and why this page no longer prints one. MGMA reports per-specialty percentiles inside DataDive, which is gated and cannot be read: https://www.mgma.com/datadive/provider-compensation . The American Society for Gastrointestinal Endoscopy runs a Gastroenterology Compensation Benchmarking survey carrying more than fifty benchmarks, open only to participants; its current round collects fiscal or calendar 2025 data and closes 31 August 2026, so no results are published: https://www.asge.org/home/resources/compensation-resources . AMGA's 2025 Medical Group Compensation Survey, its 38th edition covering 2024 data from about 500 medical groups and 184,500 providers, reports medians without percentile breakdowns and names no specialty in its public release: https://www.amga.org/about-amga/newsroom/press-releases/2025/june/new-amga-survey-notes-significant-gains-in-physician-compensation . Removed from this footnote on 2026-08-13: MedMoneyGuide, "Gastroenterology Salary (2026): The Endoscopy Center Model," which supplied a four-point MGMA wRVU percentile ladder (25th ~$378,200 to 90th ~$817,400), ASC per-procedure economics and ownership distributions, sub-subspecialty pay ranges, metro figures, an academic-versus-private gap, and a top-earner figure of $2,450,000+. It attributes its percentiles to MGMA and cannot link to MGMA, which is the definition of the excluded class in this site's sourcing standard. Searched independently, the $2,450,000 figure returns exactly one host: MedMoneyGuide itself. No survey, society publication or peer-reviewed study gives a 90th-percentile gastroenterology figure of any value. ⟳ ↩ ↩2 ↩3

  9. Endoscopy-center ownership: the mechanism is documented, the magnitude is not. Clinical Gastroenterology and Hepatology, "What to Do With My Ambulatory Surgery Center" (2011), https://www.cghjournal.org/article/S1542-3565(11)01225-0/fulltext , and "New Models of GI Practice," https://www.cghjournal.org/article/S1542-3565(17)31199-0/fulltext ; Gastrointestinal Endoscopy (ASGE), "Ambulatory endoscopy centers: what the interviewing fellow needs to know" (2005), https://www.giejournal.org/article/S0016-5107(05)01737-2/fulltext . These establish that total reimbursement to an endoscopist is greatest in a facility they own, and that in-house or joint-venture anesthesia and pathology are further income levers. None of them, and no survey, publishes a per-physician dollar figure for ASC distributions. Both journal hosts return HTTP 403 to automated tools, which is a bot policy rather than a dead link. Removed on 2026-08-13: the illustrative ASC arithmetic this page carried (a 6,000-procedure center generating ~$6M, netting ~$3.6M, a 15% stake yielding ~$540,000 a year), the per-procedure facility and professional fee dollar values, the $100,000–$300,000 buy-in range, and a "$75,000–$200,000+ a year" conservative estimate. All traced to a content republisher or a staffing agency, and a derived figure built on an unsourced input is not more reliable than its input. ⟳ Corrected 2026-08-17: the FLI section still called them "the million-dollar ASC outcomes," which is a magnitude claim and the last surviving trace of the figures removed above, on a page that tells the reader four separate times that nobody publishes this number. The magnitude is gone; the ownership mechanism stays. ↩ ↩2 ↩3 ↩4 ↩5

  10. Starting offers and workforce shortage. Merritt Hawkins regional starting salaries and HRSA workforce-shortage projections (a shortfall of ~720 GI FTEs by 2028 and ~1,390 by 2037, concentrated outside metropolitan areas), relayed by All Star Healthcare, "Gastroenterologist Salary Guide 2026": https://allstarhealthcaresolutions.com/blog/gastroenterologist-salary-guide/ . Read with two cautions. All Star is a locum staffing agency, so where it publishes rates for work it sells, the seller is publishing the price; those figures — a practical floor, practice-structure ranges, locum hourly and daily rates, a conservative ASC-ownership estimate, and GI-specific sign-on bonus dollars — have been removed from this page. The Merritt Hawkins regional figures and the HRSA projections originate elsewhere and are kept, at one remove. AMN's own Review of Physician and Advanced Practitioner Recruiting Incentives publishes signing bonuses as an all-physician average rather than by specialty: https://www.amnhealthcare.com/siteassets/amn-insights/physician/incentive-review-2024-final.pdf ⟳ ↩ ↩2 ↩3 ↩4

  11. Cross-specialty burnout reference. AMA Organizational Biopsy 2025 (~19,000 physician responses, 106 health systems, 38 states) puts Gastroenterology at 43.5% against a 41.9% all-physician average, tied with cardiology at the foot of the nine specialties it names as most burned out, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. Corrected 2026-08-17: the dashboard and the body now lead with the AMA row. AMA is the instrument this page prefers wherever it publishes a row, because it is free, primary and current, and the two baselines are seven points apart and never share a sentence. Note that the ~53% carried elsewhere on this page is a different construct, the composite of burnout, depression, or both, and is not comparable to either cross-specialty rate. The Medscape reading kept beside it: gastroenterology 50%, mid-pack against an all-physician average of 49%. Medscape Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023). The report is paywalled and returns HTTP 402, so the row reaches this site through three independent relays that agree on the edition, the instrument, and every specialty: Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout). ↩ ↩2 ↩3

  12. Medscape Gastroenterologist Mental Health & Well-Being Report 2025 — burnout ~53% (29% burnout / 10% depression / 14% both), ~79% believe balance attainable, satisfaction paradox. Via Healthgrades, "6 Statistics on Burnout Among Gastroenterologists" (https://resources.healthgrades.com/pro/6-fast-facts-about-burnout-among-gastroenterologists, 2025); Medscape (https://www.medscape.com/sites/public/mental-health/2025, 2025). A second, freely readable instrument: the AMA's 2025 Organizational Biopsy (~19,000 physicians, 38 states) puts Gastroenterology at 43.5% against a 41.9% all-physician average, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. It is primary where Medscape reaches this page through relays, and its baseline sits seven points below Medscape's 49% — the two never belong in the same sentence, and a cross-specialty rank must name which survey it comes from. ↩ ↩2 ↩3 ↩4 ↩5

  13. Women in GI. Current fellow share: ACGME, Data Resource Book Academic Year 2024-2025, Table C.21 (Number of Active Residents by Specialty and Subspecialty and Sex) — gastroenterology, under internal medicine: 242 programs, 2,152 active fellows, 873 women (40.6%), 1,278 men (59.4%), 1 not reported. https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf (2025). Decade trend: "Trends in female representation in gastroenterology fellowships in the United States" — 2009–2019 fellowship average ~33.6%, rising ~3.3 points across the decade (PubMed 36406975, 2022, https://pubmed.ncbi.nlm.nih.gov/36406975/). Practicing workforce skews more male (high teens to ~20%, estimated). Corrected 2026-08-17: the body said "the newest single-year fellow figure likely sits in the mid-to-high 30s, an estimate rather than a published number," and the dashboard printed ~34%. The figure is published, in the Data Resource Book now cited above, and it is 40.6%, above the estimate and 6.6 points above the dashboard. The ACGME newsroom release previously cited here is a summary product that does not carry the per-subspecialty sex table; the Data Resource Book does. ↩ ↩2

  14. GI personality / who gravitates. Weston Bettner, MD, Doximity Op-Med (https://opmed.doximity.com/articles/to-this-gastroenterologist-the-field-is-an-all-you-can-eat-buffet-d9772824-5702-4672-86d3-428120c8429c, 2017); AMA Specialty Profiles, shadowing gastroenterology (https://www.ama-assn.org/medical-students/preparing-residency/what-its-gastroenterology-shadowing-dr-jorgensen, 2026). ↩

  15. Matthew Moeller, MD — KevinMD, "This is what life is like for a gastroenterologist." https://kevinmd.com/2016/04/this-is-what-life-is-like-for-a-gastroenterologist.html (2016). ↩

  16. Weston Bettner, MD — Doximity Op-Med, "To This Gastroenterologist, the Field Is an 'All-You-Can-Eat Buffet.'" https://opmed.doximity.com/articles/to-this-gastroenterologist-the-field-is-an-all-you-can-eat-buffet-d9772824-5702-4672-86d3-428120c8429c (2017). ↩

  17. Sub-subspecialty training paths (advanced/interventional endoscopy, transplant hepatology, IBD, motility, general GI with ASC ownership). Training structure and certification from AASLD hepatology training pathways and ABIM certification policy; practice descriptions from the GI literature cited above. The dollar ranges that used to sit on each of these five lines — advanced endoscopy $650,000–$1,000,000+, transplant hepatology $600,000–$800,000, IBD $500,000–$650,000, motility $450,000–$600,000, general GI with ASC ownership $700,000–$1,000,000+ — came from MedMoneyGuide, a republisher that attributes figures to MGMA without linking to MGMA. No survey publishes compensation for any GI sub-subspecialty. The ranges were removed rather than relabeled; the relative ordering is kept, because it follows from procedural volume and setting rather than from the removed numbers. ⟳ ↩ ↩2 ↩3 ↩4 ↩5

Researched with AI assistance and reviewed by hand. How this site is made